Oak Hill Bio Ltd
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants (NCT04506619) | Oak Hill Bio Ltd | 2020-09-09 |
Track Oak Hill Bio Ltd automatically
Every clearance here is in the API, with alerts when new ones post.